Market Tracker

05/26 3:27am ET

Clovis Oncology Inc (NASDAQ:CLVS)

90.76
Delayed Data
As of May 22
 +0.23 / +0.25%
Today’s Change
35.33
Today|||52-Week Range
102.28
+62.07%
Year-to-Date

Today’s Trading

Previous close90.53
Today’s open90.25
Day’s range90.10 - 92.73
Volume689,471
Average volume (3 months)707,342
Market cap$3.1B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-60.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales139.29
Price/Book9.30

Competitors

 Today’s
change
Today’s
% change
WXWuXi PharmaTech (Cay...-0.13-0.30%
RAREUltragenyx Pharmaceu...-1.76-2.07%
IPXLImpax Laboratories I...+0.75+1.65%
ANACAnacor Pharmaceutica...+1.94+3.06%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$2.06
Annual revenue (last year)$13.6M
Annual profit (last year)-$160.0M
Net profit margin-1,174.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial Officer, Secretary &
Executive VP
Erle T. Mast
Corporate headquarters
Boulder, Colorado

Forecasts